Navigation Links
WNDM Secures Additional International Sales; $150 K in New Orders for 2011
Date:4/7/2011

FORT WORTH, Texas, April 7, 2011 /PRNewswire/ -- Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions, today announced that its Pharma Tech International Joint Venture, which sells wound care products within key international markets, has received new orders for the Company’s line of CellerateRX® powder and gel products.  In Lebanon, the subsidiary just completed a $50,000 order for powder and gel with a second $100,000 order scheduled for shipment later this Month with expectations to ramp up to larger orders by 3rd quarter. 

According to Deborah Jenkins Hutchinson, President of Wound Management Technologies, “I am very excited by these orders and the prospect for further growth in overseas sales.  We believe that the international market represents a significant opportunity for our products due, in part, to the region’s high rate of diabetes and its associated complications.”

For additional news and information concerning the CellerateRx® line of wound care products, please visit Wound Management Technology’s newly relaunched product website www.CellerateRX.com.

About Wound Management Technologies, Inc.

Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage.  More information can be found on the company's web sites: http://www.wmgtech.com and http://www.celleraterx.com.

Follow us on: FACEBOOK | TWITTER | LINKEDIN

Safe Harbor Statement:

The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Wound Management Technologies Shareholder Information please call (917) 974-9872 or visit http://www.wmgtech.com


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
2. ACT Secures Patent to Generate Embryonic Stem Cells Without Embryo Destruction
3. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
4. SeraCare Life Sciences Secures $20 Million Credit Facilities
5. Medizone International Secures $10,000,000 Funding Commitment
6. aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
7. Omeros Secures $40 Million Committed Equity Financing Facility
8. SPO Medical Secures Agreement in Sleep Apnea Market
9. Biolaxy Secures IND Approval for Oral Insulin
10. Osteotech Secures 10-Year Tissue Supply Agreement
11. Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... FireflySci has been manufacturing quartz ... all over the globe. Their cute firefly logo has been spreading to more ... makes spectrophotometer calibration standards that never require recalibration. These revolutionary standards have ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Ankle ... plating options designed to address fractures of the distal tibia and fibula. This ... Acumed Ankle Plating System 3 is composed of seven plate families that span ...
(Date:5/25/2016)... ... ... Scientists at the University of Athens say they have evidence that the ... research that could lead to one good one. Surviving Mesothelioma has just posted an ... The team evaluated 98 mesothelioma patients who got a second kind of ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding ... has granted the company’s orphan drug designation request covering BHV-4157 for the treatment ... by the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):